COLUMN GROUP III GP, LP sold 27.3% of their position (829.73K shares) of TENAYA THERAPEUTICS, INC. on the open market
Open‑market sale worth $504.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 2/24/2026ACC: 0001193125-26-067007
10% Owner
Since Jul 2021
-829.73K
Net shares
Net seller
$504.8K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
829.73K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−245.97K
Price / share
$0.61
Trade value
$151.24K
% of position
10.5%
2/20/2026
2.35M→2.10M
Common Stock
Indirect
Shares
−277.77K
Price / share
$0.61
Trade value
$170.80K
% of position
10.5%
2/20/2026
2.65M→2.37M
Common Stock
Indirect
Shares
−143.71K
Price / share
$0.60
Trade value
$85.82K
% of position
6.8%
2/23/2026
2.10M→1.96M
Common Stock
Indirect
Shares
−162.29K
Price / share
$0.60
Trade value
$96.92K
% of position
6.8%
2/23/2026
2.37M→2.21M
Total
Net shares
−829.73K
Net value
-$504.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 2/20/2026 | S · Sale | −245.97K | $0.61 | $151.24K | 10.5% | 2.35M | 2.10M |
| Common Stock Indirect | 2/20/2026 | S · Sale | −277.77K | $0.61 | $170.80K | 10.5% | 2.65M | 2.37M |
| Common Stock Indirect | 2/23/2026 | S · Sale | −143.71K | $0.60 | $85.82K | 6.8% | 2.10M | 1.96M |
| Common Stock Indirect | 2/23/2026 | S · Sale | −162.29K | $0.60 | $96.92K | 6.8% | 2.37M | 2.21M |
| Total | −829.73K | -$504.79K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned49.31M
Total
49.31M indirect49.31M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 49.31M | Indirect |
| Total | 49.31M | 49.31M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported